MedCath (MDTH) Reports Q2 Adj-EPS of $0.31, Beats by 11c
More News related to MDTH
- MedCath Corporation to Hold Conference Call on Fourth Quarter Results
- MedCath (MDTH) Sells Sun City Cardiac Center Associates to Banner Health
- MedCath Sells Sun City Cardiac Center Associates to Banner Health
- MedCath (MDTH) Appoints Art Parker as CFO
- MedCath Names Art Parker Executive Vice President and Chief Financial Officer
More News related to Earnings
- Notable Analyst Rating Changes 11/10: ADBE, ANN, FRPT, RAX Upgraded; ALU, CPST, PIKE, TRW Downgraded
- Morning Movers 11/10: UPG, CYD, PCLN, FLL, BZH Higher; RHIE, OPXT, PRKR, PIKE, MBI, SDTH Lower
- Notable Mergers and Acquisitions of the Day 11/10: HSC
- After-Hours Movers 11/09: SGK, PCLN, SQNM Higher; MBI, SDTH, UTK, TOPS, CPST, BTN, FLR Lower
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
MedCath Corporation (Nasdaq: MDTH) reports Q2 EPS of $0.31, ex-items, 11 cents better than the analyst estimate of $0.20. Revenue for the quarter was $158.9 million, versus the consensus of $158.64 million.
Related Categories
EarningsStocks Mentioned
-0.09Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
